Company Overview
- Headquarters
- 351 Paseo Nuevo Fl 2, Santa Barbara CA
- Website
- cancervax.com
- Phone
- (805) 356-1810
- Employees
- 12
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 325 CompaniesNAICS Code 3254 CompaniesNAICS Code 32541 CompaniesNAICS Code 32 Companies
- SIC Code
-
SIC Code 2834 CompaniesSIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$33B
Who is CancerVAX
CancerVAX is a privately held company based in Santa Barbara, California. Employing 12 people, the company focuses its efforts on the challenging field of oncology. CancerVAX is dedicated to developing innovative treatments for cancer. Their primary focus is on creating a universal cancer vaccine designed to provide broad protection against multiple types of cancer. Additionally, they are actively researching and developing a therapeutic specifically targeted at Ewing sarcoma, a rare and aggressive bone cancer. CancerVAX distinguishes itself through its research into groundbreaking technologies aimed at immunotherapies. Their dedication to developing a universal cancer vaccine represents a potentially transformative approach to cancer treatment, offering the possibility of long-term protection against a wide range of cancers. To learn more about CancerVAX and their research, visit their website at cancervax.com.
Company Leadership
CancerVAX Industry Tags
Companies Similar to CancerVAX
Analyze industry trends and opportunities by examining competitors and companies comparable to CancerVAX, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 33M | 65 | 1980 | ||
| 32M | 10 | Amherst, NH | 2011 | |
| 32M | 10 | Brentwood, TN | ||
| 32M | 92 | Moreno Valley, CA | 2014 | |
| 32M | 334 | Waterloo, IA | 2019 |